MiNK Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-12.8M | $-13.1M | $249.0K | $1.7M |
| FY2022 | $-18.9M | $-19.1M | $250.0K | $3.0M |
| FY2023 | $-15.8M | $-15.8M | $73.6K | $3.9M |
| FY2024 | $-9.6M | $-9.6M | — | $1.8M |
| FY2025 | $-5.9M | $-5.9M | — | $2.7M |